MarketScreener Homepage > Equities > Xetra > Carl Zeiss Meditec AG AFX DE0005313704

Report

Delayed Xetra - 10/29 12:35:15 pm
109.5	EUR		-2.75%

10/29

CARL ZEISS MEDITEC : Ad Hoc Announcement 29-Oct-2020

10/29

CARL ZEISS MEDITEC AG : Berenberg reiterates its Neutral rating

10/29

CARL ZEISS MEDITEC : concludes fiscal year 2019/20 with a recovery in profit in fourth quarter - outlook remains uncertain due to COVID-19 pandemic

Summary

Quotes 5-day view Delayed Quote.

Delayed Xetra

10/23/2020	10/26/2020	10/27/2020	10/28/2020	10/29/2020	Date
118.7(c)	116.2(c)	115.8(c)	112.6(c)	109.5(c)	Last
215 714	141 517	169 656	215 518	268 827	Volume
-2.55%	-2.11%	-0.34%	-2.76%	-2.75%	Change

More quotes

Financials

Sales 2020	1 372 M 1 602 M 1 602 M
Net income 2020	121 M 141 M 141 M
Net cash position 2020	556 M 650 M 650 M
P/E ratio 2020	78,2x
Yield 2020	0,50%

Sales 2021	1 484 M 1 733 M 1 733 M
Net income 2021	165 M 193 M 193 M
Net cash position 2021	651 M 760 M 760 M
P/E ratio 2021	61,0x
Yield 2021	0,63%

Capitalization	9 794 M 11 420 M 11 437 M
EV / Sales 2020	6,73x
EV / Sales 2021	6,16x
Nbr of Employees	3 335
Free-Float	40,9%

More Financials

Company

Carl Zeiss Meditec AG specializes in the production and marketing of ophthalmologic diagnosis systems and equipment. The group also manufactures and sells microsurgical visualization systems and ophthalmic surgery equipment. Net sales break down by family of products as follows: - ophthalmologic diagnosis systems and equipment (73.2%): slit lamps, corneal topography systems, retinal imaging systems, keratometers,...

Sector

Advanced Medical Equipment & Technology

Calendar

12/11

Earnings Release

More about the company

Notations Surperformance© of Carl Zeiss Meditec AG

Trading Rating :

Investor Rating :

More Ratings

All news about CARL ZEISS MEDITEC AG

10/29	CARL ZEISS MEDITEC : Ad Hoc Announcement 29-Oct-2020	PU
10/29	CARL ZEISS MEDITEC AG : Berenberg reiterates its Neutral rating	MD
10/29	CARL ZEISS MEDITEC : concludes fiscal year 2019/20 with a recovery in profit in ..	EQ
10/23	CARL ZEISS MEDITEC AG : UBS is now Neutral	MD
10/23	CARL ZEISS MEDITEC AG : Hauck & Aufhauser gives a Neutral rating	MD
10/06	CARL ZEISS MEDITEC AG : Hauck & Aufhauser reaffirms its Buy rating	MD
09/23	CARL ZEISS MEDITEC AG : Gets a Neutral rating from Berenberg	MD
09/18	CARL ZEISS MEDITEC AG : Hauck & Aufhauser reiterates its Buy rating	MD
09/11	CARL ZEISS MEDITEC : ZEISS Medical Technology Nominated for Deutscher Zukunftspr..	AQ
09/07	CARL ZEISS MEDITEC AG : Notification and public disclosure of transactions by pe..	EQ
09/02	CARL ZEISS MEDITEC AG : From Neutral to Buy by Hauck & Aufhauser	MD
08/27	CARL ZEISS MEDITEC : Effectiveness and efficiency of targeted intra-operative si..	AQ
08/19	CARL ZEISS MEDITEC AG : Independant Research maintains a Sell rating	MD
08/10	CARL ZEISS MEDITEC AG : DZ Bank lowers its rating to Sell	MD
08/10	CARL ZEISS MEDITEC AG : NorldLB reiterates its Buy rating	MD

More news

News in other languages on CARL ZEISS MEDITEC AG

10/29	Aktien Frankfurt Schluss: Dax schliesst nach Achterbahnfahrt im Plus
10/29	CARL ZEISS MEDITEC : Ad hoc Mitteilung 29.10.2020
10/29	CARL ZEISS MEDITEC AG : Berenberg est neutre sur le titre
10/29	Berenberg belässt Carl Zeiss Meditec auf 'Hold' - Ziel 87 Euro
10/29	DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 29.10.2020 - 15.15 Uhr

More news

Analyst Recommendations on CARL ZEISS MEDITEC AG

10/29	CARL ZEISS MEDITEC AG : Berenberg reiterates its Neutral rating	MD
10/23	CARL ZEISS MEDITEC AG : UBS is now Neutral	MD
10/23	CARL ZEISS MEDITEC AG : Hauck & Aufhauser gives a Neutral rating	MD

More recommendations

Provided by Scoopnest.com

Chart CARL ZEISS MEDITEC AG

Duration : Period :

Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends CARL ZEISS MEDITEC AG

	Short Term	Mid-Term	Long Term
Trends	Bullish	Bullish	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	HOLD
Number of Analysts	12
Average target price	101,08 €
Last Close Price	109,50 €
Spread / Highest target	32,4%
Spread / Average Target	-7,69%
Spread / Lowest Target	-52,5%

Consensus

EPS Revisions

More Estimates Revisions

Managers

Name	Title
Ludwin Monz	President & Chief Executive Officer
Michael Kaschke	Chairman-Supervisory Board
Justus Felix Wehmer	Chief Financial Officer
Markus Guthoff	Member-Supervisory Board
Cornelia Grandy	Member-Supervisory Board

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

CARL ZEISS MEDITEC AG	-3.69%	11 840



THERMO FISHER SCIENTIFIC	46.74%	188 581
DANAHER CORPORATION	51.22%	164 879
INTUITIVE SURGICAL, INC.	16.35%	80 855
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	117.15%	67 575
BOSTON SCIENTIFIC CORPORATION	-24.66%	48 743

More Results